comparemela.com

Ajit Ramalingam News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Bio-Rad Laboratories, Inc (NYSE:BIO) Shares Sold by Grantham Mayo Van Otterloo & Co LLC

Grantham Mayo Van Otterloo & Co. LLC decreased its holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO – Free Report) by 2.7% in the first quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 65,400 shares of the medical research company’s stock after selling 1,800 shares during the quarter. Grantham […]

American Century Companies Inc Acquires 34,008 Shares of Bio-Rad Laboratories, Inc (NYSE:BIO)

American Century Companies Inc. grew its holdings in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO – Free Report) by 261.5% in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 47,011 shares of the medical research company’s stock after purchasing an additional 34,008 shares during the quarter. […]

M&T Bank Corp Purchases 236 Shares of Bio-Rad Laboratories, Inc (NYSE:BIO)

M&T Bank Corp Purchases 236 Shares of Bio-Rad Laboratories, Inc (NYSE:BIO)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Tamarack Advisers LP Invests $479,000 in Bio-Rad Laboratories, Inc (NYSE:BIO)

Tamarack Advisers LP Invests $479,000 in Bio-Rad Laboratories, Inc (NYSE:BIO)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Bio-Rad Laboratories (NYSE:BIO) Price Target Lowered to $525 00 at Wells Fargo & Company

Bio-Rad Laboratories (NYSE:BIO – Get Free Report) had its price objective decreased by equities researchers at Wells Fargo & Company from $550.00 to $525.00 in a research report issued on Monday, Marketbeat.com reports. The firm presently has an “overweight” rating on the medical research company’s stock. Wells Fargo & Company‘s target price would suggest a […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.